No connection

Search Results

NMRK vs SBRA

NMRK
Newmark Group, Inc.
BULLISH
Price
$15.73
Market Cap
$4.03B
Sector
Real Estate
AI Confidence
75%
SBRA
Sabra Health Care REIT, Inc.
BEARISH
Price
$20.68
Market Cap
$5.21B
Sector
Real Estate
AI Confidence
85%

Valuation

P/E Ratio
NMRK
23.13
SBRA
32.31
Forward P/E
NMRK
7.43
SBRA
26.34
P/B Ratio
NMRK
1.96
SBRA
1.84
P/S Ratio
NMRK
1.22
SBRA
6.72
EV/EBITDA
NMRK
13.8
SBRA
17.18

Profitability

Gross Margin
NMRK
100.0%
SBRA
65.19%
Operating Margin
NMRK
12.53%
SBRA
23.7%
Profit Margin
NMRK
3.83%
SBRA
20.06%
ROE
NMRK
9.45%
SBRA
5.59%
ROA
NMRK
2.58%
SBRA
3.07%

Growth

Revenue Growth
NMRK
15.3%
SBRA
15.8%
Earnings Growth
NMRK
146.9%
SBRA
-44.7%

Financial Health

Debt/Equity
NMRK
1.2
SBRA
0.9
Current Ratio
NMRK
1.05
SBRA
1.8
Quick Ratio
NMRK
0.45
SBRA
1.47

Dividends

Dividend Yield
NMRK
0.76%
SBRA
5.8%
Payout Ratio
NMRK
17.65%
SBRA
187.5%

AI Verdict

NMRK BULLISH

NMRK presents a compelling value opportunity characterized by a stable Piotroski F-Score of 4/9 and a significant disconnect between its current price ($15.73) and its growth-based intrinsic value ($20.06). While the Graham Number suggests a more conservative floor of $11.09, the Forward P/E of 7.43 indicates the market is severely underpricing expected earnings growth. Explosive YoY earnings growth of 146.9% and a consistent track record of beating estimates provide a strong fundamental tailwind, though tight short-term liquidity remains a concern.

Strengths
Exceptional Forward P/E of 7.43 suggesting deep undervaluation
Massive YoY Earnings Growth of 146.90%
Strong earnings beat track record (3 of last 4 quarters)
Risks
Poor short-term liquidity indicated by a Quick Ratio of 0.45
Bearish technical trend (0/100) suggesting negative short-term momentum
Moderate leverage with a Debt/Equity ratio of 1.20
SBRA BEARISH

SBRA presents a precarious financial profile with a Piotroski F-Score of 4/9, indicating only stable, non-strong health. The stock is trading at a severe premium to both its Graham Number ($12.71) and Intrinsic Value ($4.48), while maintaining a dangerous dividend payout ratio of 187.5%. Despite double-digit revenue growth, the company is experiencing a sharp contraction in earnings (-44.7% YoY), suggesting a fundamental disconnect between top-line growth and profitability. The combination of bearish technicals, negative insider sentiment, and unsustainable dividends suggests a value trap despite optimistic analyst targets.

Strengths
Strong revenue growth (15.8% YoY)
High gross margins (65.19%)
Manageable Debt/Equity ratio (0.90) compared to sector average
Risks
Unsustainable dividend payout ratio (187.5%)
Severe earnings collapse (-44.7% YoY)
Significant overvaluation relative to Graham and Intrinsic values

Compare Another Pair

NMRK vs SBRA: Head-to-Head Comparison

This page compares Newmark Group, Inc. (NMRK) and Sabra Health Care REIT, Inc. (SBRA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile